Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Alifano, A. Lupo, N. Roche, A. Bobbio, J. F. Regnard, I. Cremer, M. C. Dieu-Nosjean, D. Damotte (Paris, France). Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer. Eur Respir J 2014; 44: Suppl. 58, 505

Member's Comments

No comment yet.

Related content which might interest you: CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Neutrophil to lymphocyte ratio (NLR) as a predictor of poor prognosis in advanced non-small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients? Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Prognostic factors in non-small cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Surgical treatmment non-small cell lung cancer in the elderly patients Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015